Table 1.
Measure | Baseline | Post CPF application | P-value |
---|---|---|---|
Urinary TCPy (µg/g creatinine) | |||
N | 100 | 97 | < 0.001a |
Mean ± SD | 18.4 ± 73.4 | 49.1 ± 177.8 | |
Median | 7.0 | 15.9 | |
Range | 1.5 – 734 | 2.9 – 1664 | |
Plasma BuChE (U/ml) | |||
N | 100 | 97 | < 0.001b |
Mean ± SD | 1.77 ± 0.52 | 1.59 ± 0.52 | |
Median | 1.75 | 1.64 | |
Range | 0.49 – 3.65 | 0.36 – 2.82 | |
RBC AChE (U/g Hgb) | |||
N | 100 | 97 | 0.018b |
Mean ± SD | 28.3 ± 3.5 | 27.7 ± 3.2 | |
Median | 28.4 | 26.8 | |
Range | 11.7 – 37.3 | 19.0 – 37.5 | |
CPOase (U/l) | |||
N | 67 | 67 | 0.398b |
Mean ± SD | 3680 ± 1140 | 3772 ± 1216 | |
Median | 3668 | 3829 | |
Range | 1286 – 6348 | 1329 – 7030 | |
POase (U/l) | |||
N | 67 | 67 | 0.053b |
Mean ± SD | 83.5 ± 39.3 | 78.3 ± 35.2 | |
Median | 77.4 | 73.4 | |
Range | 23.8 – 171.2 | 18.0 – 173.4 |
P-value compares measures collected at baseline to post CPF application using
Wilcoxon sign rank test or
paried t-test